Agilent Q1 Revenues Rise 8 Percent as Life Sciences Bounce 14 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies said after the close of the market on Wednesday that fiscal first-quarter revenues for 2012 climbed 8 percent year over year, as Life Sciences revenues increased 14 percent.

Total revenues for the three months ended Jan. 31, reached $1.64 billion, compared to $1.52 billion a year ago, and just short of consensus analyst expectations of $1.65 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.